Cool Company Raises · $129.0M
Scribe Therapeutics raises a $129.0M round
Scribe is enabling the creation of genetic medicines through its CRISPR by Design™ approach to genetic modification.
Visit source
Get the next one by email
One brief each weekday morning. One-click unsubscribe.